STOCK TITAN

[144] Amylyx Pharmaceuticals, Inc. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

AMLX insider Joshua Barry Cohen has filed a notice of proposed sale of company stock under Rule 144. The filing covers the planned sale of 1,974 common shares through Morgan Stanley Smith Barney LLC on the NASDAQ, with an aggregate market value of $26,688.48 based on the figures provided. The shares relate to an exercise of stock options on 01/16/2026, paid for in cash and acquired from the issuer on the same date.

The notice states that AMLX had 109,819,569 shares of common stock outstanding. Over the prior three months, sales for Cohen’s account included 136,193 common shares on 01/15/2026 for gross proceeds of $1,850,794.52 and 7,715 common shares on 01/06/2026 for gross proceeds of $85,596.38. By signing, the seller represents that he is not aware of undisclosed material adverse information about the issuer.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Amylyx Pharmaceuticals

NASDAQ:AMLX

AMLX Rankings

AMLX Latest News

AMLX Latest SEC Filings

AMLX Stock Data

1.57B
91.64M
9.5%
94.68%
9.43%
Biotechnology
Pharmaceutical Preparations
Link
United States
CAMBRIDGE